PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Sodium Ferric Gluconate Complex→

Sodium Ferric Gluconate Complex PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
34089-81-1
Molecular formula
Not a single fixed molecule
FDA structural formula
[NaFe2O3(C6H11O7)(C12H22O11)5]n, n ≈ 200
Apparent molecular weight
289,000–440,000 Da (gel chromatography)

Identification source: FDA Ferrlecit prescribing information describes this as a stable macromolecular complex, gives the structural formula shown, and reports the apparent molecular-weight range by gel chromatography. The range reflects the complex rather than a single small molecule.

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Sodium Ferric Gluconate Complex PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Sodium Ferric Gluconate Complex Permitted Daily Exposure (PDE) report (the Sodium Ferric Gluconate Complex PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Sodium Ferric Gluconate Complex Occupational Exposure Limit (OEL) report (the Sodium Ferric Gluconate Complex OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.